Functional gastrointestinal disorders in 2007 and Rome III: Something new, something borrowed, something objective

Reviews in Gastroenterological Disorders

Volumn 7, Issue 2, 2007, Pages 97-105

  Talley, Nicholas J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cyclic vomiting syndrome; Dyspepsia; Functional gastrointestinal disorders; Irritable bowel syndrome; Rome III; Sphincter of Oddi dysfunction

Indexed keywords

BILIARY TRACT PAIN; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; EPIGASTRIC PAIN; GALLBLADDER DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; NAUSEA; REVIEW; SYSTEMATIC REVIEW; VATER PAPILLA STENOSIS; VOMITING;

DYSPEPSIA; GASTROINTESTINAL DISEASES; HUMANS; MENTAL DISORDERS; PRACTICE GUIDELINES; RECTAL DISEASES; SPHINCTER OF ODDI DYSFUNCTION; SYNDROME; VOMITING;

EID: 34250874454     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, healthcare seeking and emerging risk factors. Gastroenterol Clin North Am. 2005;34:189-204.
2. Drossman DA, Corrazziari E, Delvaux M, et al. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates; 2006.
3. Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225-235.
4. Drossman DA, Richter JE, Talley NJ. The Functional Gastrointestinal Disorders. 1st ed. Boston: Little, Brown and Company; 1994.
5. Talley NJ. Irritable bowel syndrome. Intern Med J. 2006;36:724-728.
6. Talley NJ. Genes and environment in irritable bowel syndrome: one step forward. Gut. 2006; 55:1694-1696.
7. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390.
8. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-1479.
9. Moayyedi P, Delaney B, Vakil N, et al. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004;127:1329-1337.
10. Talley N, Vakil NB, Moayyedi P. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology. 2005;129:1756-1780.
11. Feinle-Bisset C, Vozzo R, Horowitz M, et al. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol. 2004;99:170-181.
12. Hyman PE, Milla PJ, Benninga MA, et al. Childhood functional gastrointestinal disorders: neonate/ toddler. Gastroenterology. 2006;130:1519-1526.
13. Fleischer DR, Gornowicz B, Adams K, et al. Cyclic vomiting syndrome in adults: a report of 41 patients [abstract]. Am J Gastroenterol. 2005; 100:S322.
14. Prakash C, Clouse RE. Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants. Am J Gastroenterol. 1999;94:2855-2860.
15. Fajardo NR, Cremonini F, Talley NJ. Cyclic vomiting syndrome and chronic cannabis use [abstract]. Am J Gastroenterol. 2005;100(suppl 9):S343.
16. Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53:1566-1570.
17. Chitkara DK, Van Tilburg M, Whitehead WE, et al. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol. 2006;101:2449-2452.
18. Chitkara DK, Bredenoord AJ, Talley NJ, et al. Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol. 2006; 9:305-313.
19. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.
20. Cash BD, Chey WD. Irritable bowel syndrome - an evidence-based approach to diagnosis. Aliment Pharmacol Ther. 2004;19:1235-1245.
21. Spiegel BM, DeRosa VP, Gralnek IM, et al. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology. 2004;126:1721-1732.
22. Degen LP, Phillips SF. How well does stool form reflect colonic transit? Gut. 1996;39:109-113.
23. Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005;128:580-589.
24. Muller-Lissner S, Kamm MA, Musoglu A, et al. Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation. Am J Gastroenterol. 2006;101:2558-2569.
25. Tack J, Muller-Lissner S, Bytzer P, et al. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation. Gut. 2005;54:1707-1713.
26. Chang L, Chey WD, Harris L, et al. Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data. Am J Gastroenterol. 2006;101:1069-1079.
27. Sharara AI, Aoun E, Abdul-Baki H, et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol. 2006;101:326-333.
28. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581-1590.
29. Bharucha AE, Wald A, Enck P, et al. Functional anorectal disorders. Gastroenterology. 2006;130: 1510-1518.
30. Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology. 2004;126:57-62.
31. Rao SS, Mudipalli RS, Stessman M, et al. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil 2004;16:589-596.
32. Chiarioni G, Whitehead WE, Pezza V et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130:657-664.
33. Behar J, Corazziari E, Guelrud M, et al. Functional gallbladder and sphincter of Oddi disorders. Gastroenterology. 2006;130:1498-1509.
34. Baillie J. Sphincter of Oddi dysfunction: overdue for an overhaul. Am J Gastroenterol. 2005;100: 1217-1220.
35. Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989;320:82-87.
36. Sherman S, Lehman GA. Sphincter of Oddi dysfunction: diagnosis and treatment. JOP. 2001;2:382-400.
37. Freeman ML, Gill M, Overby C, et al. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of Oddi dysfunction. J Clin Gastroenterol. 2007;41:94-102.
38. Levy RL, Olden KW, Naliboff BD, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006;130:1447-1458.
39. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21:153-160.
40. Locke GR 3rd, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17:29-34.